Nicholas Investment Partners, LP Abb Vie Inc. Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.39 Million - $1.6 Million	-10,380 Reduced 31.28%	22,800 $3.06 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $1.34 Million - $1.67 Million	10,180 Added 44.26%	33,180 $5.38 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.47 Million - $3.13 Million	23,000 New	23,000 $3.11 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $5.26 Million - $5.86 Million	-50,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $1.02 Million - $1.13 Million	10,000 Added 25.0%	50,000 $5.41 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $3.22 Million - $4.35 Million	40,000 New	40,000 $4.29 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.